MEDANTA - Swing Trade Analysis with AI Signals
Back to ListSwing Trade Rating: 3.1
| Stock Code | MEDANTA | Market Cap | 27,200 Cr. | Current Price | 1,015 ₹ | High / Low | 1,456 ₹ |
| Stock P/E | 54.3 | Book Value | 141 ₹ | Dividend Yield | 0.05 % | ROCE | 19.6 % |
| ROE | 15.2 % | Face Value | 2.00 ₹ | DMA 50 | 1,122 ₹ | DMA 200 | 1,191 ₹ |
| Chg in FII Hold | -0.87 % | Chg in DII Hold | 1.02 % | PAT Qtr | 107 Cr. | PAT Prev Qtr | 128 Cr. |
| RSI | 29.3 | MACD | -26.3 | Volume | 92,994 | Avg Vol 1Wk | 1,16,267 |
| Low price | 1,010 ₹ | High price | 1,456 ₹ | PEG Ratio | 1.72 | Debt to equity | 0.07 |
| 52w Index | 1.03 % | Qtr Profit Var | -18.4 % | EPS | 17.3 ₹ | Industry PE | 43.5 |
📊 Medanta shows weak swing trade potential in the short term. The RSI at 29.3 indicates oversold conditions, but MACD (-26.3) remains negative, suggesting continued weakness. Fundamentals are mixed: decent ROCE (19.6%) and ROE (15.2%), but valuation is stretched with a P/E of 54.3 and a very low dividend yield (0.05%). The optimal entry price would be near support around 1,000–1,020 ₹. If already holding, consider exiting near resistance around 1,120–1,150 ₹ unless momentum improves.
✅ Positive
- Reasonable ROCE (19.6%) and ROE (15.2%)
- Debt-to-equity ratio of only 0.07, showing financial stability
- DII holdings increased by 1.02%, signaling domestic investor confidence
- EPS of 17.3 ₹ supports earnings visibility
⚠️ Limitation
- High P/E ratio (54.3) compared to industry average (43.5)
- Weak technical indicators: RSI oversold, MACD negative
- Current price below both 50 DMA (1,122 ₹) and 200 DMA (1,191 ₹)
- Quarterly profit decline (PAT down from 128 Cr. to 107 Cr.)
📉 Company Negative News
- Quarterly profit variation shows a decline of -18.4%
- FII holdings decreased by -0.87%, reflecting reduced foreign investor confidence
📈 Company Positive News
- DII holdings increased by 1.02%
- Strong operational efficiency reflected in ROCE and ROE
- PEG ratio of 1.72 indicates growth is somewhat priced in
🏭 Industry
- Industry P/E at 43.5, lower than Medanta’s 54.3, suggesting overvaluation
- Healthcare sector demand remains resilient with long-term growth potential
🔎 Conclusion
Medanta is financially stable with decent efficiency ratios, but technical weakness and high valuation limit swing trade attractiveness. Entry around 1,000–1,020 ₹ is optimal, with exit near 1,120–1,150 ₹ if resistance holds. Long-term investors may continue holding due to sector resilience, while swing traders should remain cautious until momentum indicators turn positive.